Allison E Garda

No ORCID on file · 1 paper in corpus

case-report 2025

Case Report: Navigating novel therapies and systemic barriers in ovarian clear cell carcinoma through a complete response to lenvatinib, pembrolizumab, and SFRT

Frontiers in oncology ·doi:10.3389/fonc.2025.1679554

Ovarian clear cell carcinoma (OCCC) is a rare and chemoresistant histology known for having a poor prognosis and limited treatment options. Novel therapies offer hope, but come at a significant cost, with patients facing financial toxicity,…